HIV and HCV Vaccines and Immunopathogenesis.

HIV 和 HCV 疫苗和免疫发病机制。

• 批准号: nhmrc : 510448
• 负责人: A/Pr Michael Beard
• 金额: $ 1249.87万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Programs
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/hiv-hcv-vaccines-immunopathogenesis/81303
• 关键词: HIV; HCV; Vaccines; Immunopathogenesis.

The development of vaccines and better treatments for HIV-AIDS and Hepatitis C are urgent global health priorities. This Program will undertake studies to better understand effective immunity against HIV and hepatitis C, allowing the rational design and testing of novel vaccines and treatments. The Program brings together a team of researchers with skills in basic virology and immunology with those providing expertise in translating findings in the laboratory into human clinical trials.

开发艾滋病毒/艾滋病和丙型肝炎的疫苗和更好的治疗方法是紧迫的全球卫生优先事项。该方案将开展研究，以更好地了解对艾滋病毒和丙型肝炎的有效免疫，从而合理设计和试验新的疫苗和治疗方法。该规划汇集了一组具有基本病毒学和免疫学技能的研究人员，以及将实验室发现转化为人体临床试验的专业人员。